Alkermes (ALKS) Tops Q1 EPS by 1c; reiterates guidance

Alkermes (NASDAQ: ALKS) reported Q1 EPS of $0.01, $0.01 better than the analyst estimate of $0.00. Revenue for the quarter came in at $287.6 million versus the consensus estimate of $282.23 million.

Alkermes reiterates its financial expectations for 2023, as set forth in its press release dated Feb. 16, 2023.

For earnings history and earnings-related data on Alkermes (ALKS) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
• Assembly Biosciences (ASMB) Tops Q2 EPS by 53c